FIRST LOOK: New Approaches to Controlling Stem Cell Fate

pcicicic

Embryonic stem cells and induced pluripotent stem cells, which can be propagated indefinitely in culture in an undifferentiated state or induced to differentiate into every cell type in the adult body, holds promise for regenerative medicine. Proper execution of these distinct but developmentally relevant programs requires precise tuning of gene expression by transcription factors. Indeed, aberrant transcriptional regulation is the root cause of many human diseases including developmental disorders, cancers, and degenerative diseases.

We have devised various biochemical strategies to isolate and characterize critical cellular machinery responsible for transcription in stem cells, and to reconstruct the complex process of gene expression in vitro. This technique, in combination with genetic and computational methods, provides powerful tools to understand the function of these gene regulatory factors in healthy cells and the fundamental mechanism by which their misregulation can lead to human diseases and disorders.

For more information about Dr. Fong’s research, please contact Partners HealthCare Innovation by clicking here.

Most Recent Posts:

Blog MGB Implements DexCare image

Mass General Brigham Implements DexCare to Support Care Integration and Advance Digital Health

Collaboration demonstrates Mass General Brigham’s commitment to digital transformation and enhancing patient experience   SEATTLE, Oct. 31, 2022…

Read More
Blog Innovation Grand Rounds Khurana

Innovation Grand Rounds: Clinical Innovation in Trauma: From Inception to Automation to Impact

Innovation Grand Rounds is a monthly live series with talks by innovators and executives from across the…

Read More
Advamed

McKenna invited as panelist at Advamed MedTech Conference

Photo, left to right: Joseph Ferrara (moderator), Veranex Solutions; Philip Rackliffe, GE Healthcare; Erin McKenna; Kevin Boyle,…

Read More